Results 11 to 20 of about 455 (54)
Modified rush venom immunotherapy in dogs with Hymenoptera hypersensitivity
Background – Hymenoptera envenomation occurs frequently in people and dogs and can trigger anaphylaxis. Venom immunotherapy (VIT) is the only preventative treatment for Hymenoptera hypersensitivity and is indicated for people with severe adverse reactions to insect stings. Rush VIT is an accelerated VIT induction schedule performed in people.
Alexandra Moore +4 more
wiley +1 more source
Background – There are limited clinical studies evaluating the Trichophyton mentagrophytes complex, with most reports confined to small case studies. Additionally, the studies are dated and provide limited information on response to newer or currently available therapies.
Jason B. Pieper +5 more
wiley +1 more source
Background – A rebound of pruritus occasionally occurs after oclacitinib dose reduction in dogs with atopic dermatitis (AD). Objectives – To determine whether an initial 4‐day course of prednisolone decreases the probability of a pruritus rebound after reducing the frequency of oclacitinib administration.
Thierry Olivry +5 more
wiley +1 more source
Abstract Parenting interventions can improve parenting outcomes, with widespread implications for children's developmental trajectories. Relational savoring (RS) is a brief attachment‐based intervention with high potential for dissemination. Here we examine data from a recent intervention trial in order to isolate the mechanisms by which savoring ...
Jessica L. Borelli +5 more
wiley +1 more source
Treatment of equine sarcoids using recombinant poxviruses expressing feline interleukin‐2
Background – Interleukin (IL)‐2 stimulates antitumour immunity and is successfully used for the treatment of different neoplasias. Hypothesis/Objectives –Canarypox virus locally expressing feline IL‐2 is safe and can be used to treat equine sarcoids. Conclusions –Treatment of equine sarcoids with recombinant canarypox virus expressing feline IL‐2 seems
Johanna Loschelder‐Ostrowski +4 more
wiley +1 more source
Groups with normal restriction property [PDF]
Let G be a finite group. A subgroup M of G is said to be an NR-subgroup if, whenever K is normal in M, then K^G\cap M=K, where K^G is the normal closure of K in G.
Tong-Viet, Hung P.
core +1 more source
Classifying Families of Character Degree Graphs of Solvable Groups [PDF]
We investigate prime character degree graphs of solvable groups. In particular, we consider a family of graphs $\Gamma_{k,t}$ constructed by adjoining edges between two complete graphs in a one-to-one fashion.
Bissler, Mark W., Laubacher, Jacob
core +2 more sources
Background– Pseudomonas aeruginosa (PA) may cause suppurative otitis externa with severe inflammation and ulceration in dogs. Multidrug resistance is commonly reported for this organism, creating a difficult therapeutic challenge. Objective– The aim of this study was to evaluate the in vitro antimicrobial activity of a gel containing 0.5 µg/mL of ...
Giovanni Ghibaudo +6 more
wiley +1 more source
A note on p‐solvable and solvable finite groups
The notion of normal index is utilized in proving necessary and sufficient conditions for a group G to be respectively, p‐solvable and solvable where p is the largest prime divisor of |G|. These are used further in identifying the largest normal p‐solvable and normal solvable subgroups, respectively, of G.
R. Khazal, N. P. Mukherjee
wiley +1 more source
Chief factors covered by projectors of soluble Leibniz algebras
Let F be a saturated formation of soluble Leibniz algebras. Let K be an F-projector and A/B a chief factor of the soluble Leibniz algebra L. It is well-known that if A/B is F-central, then K covers A/B.
Barnes, Donald W.
core +1 more source

